Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|September 23, 2022
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapySaeid Najafi-Fard, Elisa Petruccioli, Chiara Farroni, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 19, 2017
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort studyMauro Borzio, Elena Dionigi, Alessandro Vitale, et al.Vaccines|August 29, 2024
Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 VaccinationAlessandra Aiello, Serena Ruggieri, Assunta Navarra, et al.Frontiers in Immunology|August 15, 2022
Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic waveAlessandra Aiello, Adriano Grossi, Silvia Meschi, et al.International Journal of Molecular Sciences|May 27, 2023
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster DoseSerena Ruggieri, Alessandra Aiello, Carla Tortorella, et al.Frontiers in Immunology|November 17, 2025
Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapiesAlessandra Aiello, Assunta Navarra, Shalom Haggiag, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2022
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapiesAlessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.Frontiers in Immunology|March 21, 2022
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid ArthritisChiara Farroni, Andrea Picchianti-Diamanti, Alessandra Aiello, et al.Frontiers in Immunology|October 1, 2021
ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis PatientsAndrea Picchianti-Diamanti, Alessandra Aiello, Bruno Laganà, et al.Neurology|November 23, 2021
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying TherapiesCarla Tortorella, Alessandra Aiello, Claudio Gasperini, et al.Pageof 4